MX2022001615A - Métodos sintéticos mejorados para la elaboración de compuestos de (2h 1,2,3-triazol-2-il)fenilo como moduladores del receptor de orexina. - Google Patents

Métodos sintéticos mejorados para la elaboración de compuestos de (2h 1,2,3-triazol-2-il)fenilo como moduladores del receptor de orexina.

Info

Publication number
MX2022001615A
MX2022001615A MX2022001615A MX2022001615A MX2022001615A MX 2022001615 A MX2022001615 A MX 2022001615A MX 2022001615 A MX2022001615 A MX 2022001615A MX 2022001615 A MX2022001615 A MX 2022001615A MX 2022001615 A MX2022001615 A MX 2022001615A
Authority
MX
Mexico
Prior art keywords
triazol
making
orexin receptor
synthetic methods
receptor modulators
Prior art date
Application number
MX2022001615A
Other languages
English (en)
Inventor
Cheng Yi Chen
Kiran Matcha
Depré Dominique Paul M
Florian Damien Medina
Pieter Westerduin
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2022001615A publication Critical patent/MX2022001615A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/74—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/76—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/74—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/78—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/30—Nitrogen atoms non-acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen procesos para preparar (((3aR,6aS)-5-(4,6-dimetilpiri midin-2- il)hexahidropirrolo[3,4-c]pirrol-2(1H)-il)(2-fluoro-6-(2H -1,2,3-triazol-2-il)fenil)metanona (ver fórmula) Se describen procesos para preparar (((3aR,6aS)-5-(4,6-dimetilpirimidin-2- il)hexahidropirrolo[3,4-c]pirrol-2(1H)-il)(2-fluoro-6-(2H-1,2,3-t riazol-2-il)fenil)metanona.
MX2022001615A 2019-08-07 2020-08-06 Métodos sintéticos mejorados para la elaboración de compuestos de (2h 1,2,3-triazol-2-il)fenilo como moduladores del receptor de orexina. MX2022001615A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962883857P 2019-08-07 2019-08-07
US202062971265P 2020-02-07 2020-02-07
PCT/EP2020/072192 WO2021023843A1 (en) 2019-08-07 2020-08-06 Improved synthetic methods of making (2h-1,2,3-triazol-2-yl)phenyl compounds as orexin receptor modulators

Publications (1)

Publication Number Publication Date
MX2022001615A true MX2022001615A (es) 2022-05-26

Family

ID=72139573

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022001615A MX2022001615A (es) 2019-08-07 2020-08-06 Métodos sintéticos mejorados para la elaboración de compuestos de (2h 1,2,3-triazol-2-il)fenilo como moduladores del receptor de orexina.

Country Status (15)

Country Link
US (1) US20220289754A1 (es)
EP (1) EP4010325A1 (es)
JP (1) JP2022543286A (es)
KR (1) KR20220044323A (es)
CN (1) CN114555603A (es)
AU (1) AU2020324552A1 (es)
BR (1) BR112022002128A2 (es)
CA (1) CA3149689A1 (es)
CR (1) CR20220050A (es)
EC (1) ECSP22016630A (es)
IL (1) IL290362A (es)
JO (1) JOP20220031A1 (es)
MX (1) MX2022001615A (es)
PE (1) PE20220842A1 (es)
WO (1) WO2021023843A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826833A (en) * 1984-01-30 1989-05-02 Pfizer Inc. 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
PL2491038T3 (pl) * 2009-10-23 2016-10-31 Dwupodstawione oktahydropirolo[3,4-c]pirole jako modulatory receptora oreksyny
US8299117B2 (en) * 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
ES2861589T3 (es) * 2014-04-01 2021-10-06 Bayer Cropscience Ag Uso de compuestos heterocíclicos para controlar nematodos

Also Published As

Publication number Publication date
BR112022002128A2 (pt) 2022-06-07
US20220289754A1 (en) 2022-09-15
CA3149689A1 (en) 2021-02-11
WO2021023843A1 (en) 2021-02-11
EP4010325A1 (en) 2022-06-15
CR20220050A (es) 2022-04-20
IL290362A (en) 2022-04-01
CN114555603A (zh) 2022-05-27
PE20220842A1 (es) 2022-05-24
AU2020324552A1 (en) 2022-03-24
KR20220044323A (ko) 2022-04-07
ECSP22016630A (es) 2022-04-29
JOP20220031A1 (ar) 2023-01-30
JP2022543286A (ja) 2022-10-11

Similar Documents

Publication Publication Date Title
JOP20180019A1 (ar) بيرولات [3، 4-سي] اوكتاهيدروبيرولو ثنائية الاستبدال كمعدلات لمستقبل اوريكسين
PH12019501355A1 (en) Small molecule inhibitors of the jak family of kinases
NZ630721A (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
MY196260A (en) Small Molecule Inhibitors of the Jak Family Of Kinases
NZ630719A (en) Imidazo [1, 2 - b] pyridazine - based compounds, compositions comprising them, and uses thereof
SV2018005800A (es) Moduladores alostéricos positivos del receptor muscarínico de acetilcolina m4
TW200621256A (en) Formulations
PH12021551054A1 (en) Improved synthetic methods of making fused heterocyclic compounds as orexin receptor modulators
PE20070621A1 (es) 2-amino-7,8-dihidro-6h-pirido(4,3-d)pirimidina-5-onas
SA520412192B1 (ar) مشتقات 5-(2-(2، 5-داي فلورو فنيل)بيروليدين-1-يل) -3-(1h-بيرازول-1-يل) بيرازولو[1، 5-a] بيريميدين والمركبات ذات الصلة كمثبطات كيناز trk لعلاج السرطان
ZA200704476B (en) Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
TW200613305A (en) Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
WO2010068483A3 (en) Mlk inhibitors and methods of use
MX2010007605A (es) Pirrolo-pirimidas y pirrolo-piridinas.
TW200616632A (en) Compounds modulating c-kit activity and uses therefor
MX2021015510A (es) Pirazolo[4,3-b]piridinas sustituidas y su uso como moduladores del receptor glun2b.
ZA200800992B (en) Benzimidazoles useful as inhibitors of protein kinases
EP3825317A3 (en) Process for preparing btk inhibitors
JOP20200311A1 (ar) مثبطات صغيرة الجزيئات من فئة الكينازات مزدوجة الوجه (jak)
MX2021015500A (es) Pirazolo-pirazinas sustituidas y su uso como moduladores del receptor glun2b.
PE20212196A1 (es) Compuestos, composiciones, y metodos para modular la actividad cdk9
EA202190323A1 (ru) ИМИДАЗО[1,2-b]ПИРИДАЗИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ Trk
MX2023004942A (es) Compuestos biciclicos y usos de los mismos para el tratamiento de enfermedades.
GB0522082D0 (en) Formulations
MX2023010711A (es) Fenalquilaminas y métodos de preparación y uso de las mismas.